Canopy Growth (TSX:WEED) Dumped its Visionary: Investors Should Do the Same to the Stock!

Canopy Growth Corp (TSX:WEED)(NYSE:CGC) stock has been struggling in recent months, and things might not be getting better anytime soon.

| More on:

The impact that a CEO has on a company can make a big difference in how the stock does. If Apple hadn’t been run by Steve Jobs, it’s unlikely that the company would be as admired as it is today with the cult-like following it has. The level of innovation coming from the company has noticeably declined since Jobs’s death, as the brand has seemingly become content with just making modest improvements to its popular iPhones, which, to little surprise, haven’t seen the same fanfare as in previous years.

While Bruce Linton is not on the same level as a Steve Jobs, he was certainly a big part of the reason Canopy Growth (TSX:WEED)(NYSE:CGC) had been able to climb to a valuation of more than $20 billion. Overpriced or not, investors were willing to pay a hefty premium for the cannabis stock, even though it has struggled to get anywhere near breakeven. The brand has become synonymous with the cannabis industry and likely a key reason that Acreage Holdings wanted to partner with the company.

And so, when Canopy Growth announced that Linton would no longer be its co-CEO, it was definitely a big blow to the cannabis company’s leadership. Admittedly, profitability was a big problem, but it was one that Constellation Brands, which is a key investor and the likely catalyst behind Linton’s departure, knew was going to be an issue for the foreseeable future, especially with the aggressive growth that the company had been pursuing.

By diversifying into other industries and looking to expand into the U.S. hemp market, Linton was trying to build a brand that would be versatile and that would benefit from various growth opportunities. Undoubtedly, it would have taken a long time for Canopy Growth to become a consistently profitable company. However, it was a risk that Constellation had to have been aware of and presumably was prepared to help bankroll the company’s growth.

Why it could prove to be a big mistake

Canopy Growth stock had already been on the decline in recent months, and now with many question marks surrounding the company and its future, things may get even worse. We’ve seen the impact Linton has had just by announcing he would be working with another company and the excitement that his presence is able to generate. That excitement might now be gone from Canopy Growth and it creates the opportunity for a rival company to take the spotlight.

It could even be a great opportunity for a company like Aphria, which, earlier this year, saw its CEO step down, to bring on Linton and help the struggling pot stock out. However, it’s unclear what Linton’s plans are for the time being and if he’d want to work with another cannabis company.

Under new leadership, Canopy Growth might make progress in cleaning up and improving its financials, but that might also result in other opportunities being put on the backburner, which could impact its presence in other markets and popularity with investors. The move to remove Linton seemed like a knee-jerk reaction by Constellation and Canopy Growth’s board, and I’m not so sure that it will pay off.

Should you invest $1,000 in Canadian National Railway right now?

Before you buy stock in Canadian National Railway, consider this:

The Motley Fool Stock Advisor Canada analyst team just identified what they believe are the Top Stocks for 2025 and Beyond for investors to buy now… and Canadian National Railway wasn’t one of them. The Top Stocks that made the cut could potentially produce monster returns in the coming years.

Consider MercadoLibre, which we first recommended on January 8, 2014 ... if you invested $1,000 in the “eBay of Latin America” at the time of our recommendation, you’d have $21,345.77!*

Stock Advisor Canada provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month – one from Canada and one from the U.S. The Stock Advisor Canada service has outperformed the return of S&P/TSX Composite Index by 24 percentage points since 2013*.

See the Top Stocks * Returns as of 4/21/25

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor David Jagielski has no position in any of the stocks mentioned. David Gardner owns shares of Apple. The Motley Fool owns shares of Apple and has the following options: long January 2020 $150 calls on Apple and short January 2020 $155 calls on Apple.

Confidently Navigate Market Volatility: Claim Your Free Report!

Feeling uneasy about the ups and downs of the stock market lately? You’re not alone. At The Motley Fool Canada, we get it — and we’re here to help. We’ve crafted an essential guide designed to help you through these uncertain times: "5-Step Checklist: How to Prepare Your Portfolio for Volatility."

Don't miss out on this opportunity for peace of mind. Just click below to learn how to receive your complimentary report today!

Get Our Free Report Today

More on Cannabis Stocks

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Stocks for Beginners

Buy the Dip Before It’s Too Late: This Canadian Stock Won’t Stay Cheap Forever

Investors might think that cannabis stocks are out, but this one could be the top Canadian stock to consider.

Read more »

a person watches a downward arrow crash through the floor
Stocks for Beginners

Plummet Alert: Is This TSX Growth Stock a Bargain or a Falling Knife?

This growth stock was once a major winner, but can investors wait for more?

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

What to Know About Canadian Cannabis Stocks for 2025

Let's dive into two top Canadian cannabis stocks and where they may be headed from here (given the recent moves…

Read more »

Researcher works in hemp field
Cannabis Stocks

Aurora Cannabis Stock Is up 46% in 2025: Are Investors Going From 5 Years of Pain to a 2025 Gain?

Shares of Aurora Cannabis have staged a comeback in 2025, outpacing the broader markets comfortably. Is ACB stock a good…

Read more »

A plant grows from coins.
Stocks for Beginners

3 Growth Stocks That Could Skyrocket in 2025 and Beyond

It could be a big year for these sectors, and these growth stocks in particular throughout 2025.

Read more »

money goes up and down in balance
Tech Stocks

2 TSX Stocks to Buy and 2 to Avoid in the Looming Trade War

The looming U.S.-Canada trade war has changed the business environment. Here are some TSX stocks to buy and avoid in…

Read more »

space ship model takes off
Cannabis Stocks

2 Canadian Stocks With Strong Momentum for 2025

Celestica Inc. (TSX:CLS) stock and Dollarama (TSX:DOL) stock have sustained strong price growth momentum for a long time.  Here’s why…

Read more »

Worker tags plants at an industrial cannabis operation
Cannabis Stocks

Pot Stocks: Buy, Sell, or Hold in 2025?

Cannabis stocks remain a bit risky, but could long-term investors be in for more pain or far more profits?

Read more »